Earnings Call · Q1 FY2025·2025-05-05

Q1 25EPS -35.78%·Rev n/aQ4 24EPS -12.44%·Rev n/aQ3 24EPS -0.55%·Rev n/aQ2 24EPS +6.54%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Investor Relations or Communications

Kyle Gano — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Dr. Eiry Roberts — Chief Medical Officer

+8.4%1d on move date+9.2% vs SPY3d+7.1%5d+9.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access